menu ☰
menu ˟

Genentech begins phase 2 clinical trial of ranibizumab port delivery system for wet AMD

06 Nov 2015
Genentech has initiated a phase 2 clinical trial of the ranibizumab port delivery system implant in patients with wet age-related macular degeneration, according to a company announcement.The Long Acting Delivery of Ranibizumab (LADDER) study will ev...

Click here to view the full article which appeared in Optometry

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.